Cargando…
miRNA-181a-5p Enhances the Sensitivity of Cells to Cisplatin in Esophageal Adenocarcinoma by Targeting CBLB
BACKGROUND: Cisplatin (CDDP) is extensively used for esophageal adenocarcinoma (EAC) chemotherapy, while cisplatin resistance is getting worse. microRNA-181a-5p (miR-181a-5p) has been reported to play an important role in various human cancers. However, the effect and underlying mechanism of miR-181...
Autores principales: | Yang, Song, Wang, Peng, Wang, Songhua, Cong, Aihua, Zhang, Qi, Shen, Wenhao, Li, Xiangyi, Zhang, Wei, Han, Gaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323973/ https://www.ncbi.nlm.nih.gov/pubmed/32612385 http://dx.doi.org/10.2147/CMAR.S251264 |
Ejemplares similares
-
Silencing lncRNA AFAP1-AS1 Inhibits the Progression of Esophageal Squamous Cell Carcinoma Cells via Regulating the miR-498/VEGFA Axis
por: Shen, Wenhao, et al.
Publicado: (2020) -
Immune dysregulation caused by homozygous mutations in CBLB
por: Janssen, Erin, et al.
Publicado: (2022) -
Targeting CBLB as a Potential Therapeutic Approach for Disseminated Candidiasis
por: Xiao, Yun, et al.
Publicado: (2016) -
Research of the mechanism on miRNA193 in exosomes promotes cisplatin resistance in esophageal cancer cells
por: Shi, Shifeng, et al.
Publicado: (2020) -
Circulating exosomal miRNAs as potential biomarkers for Barrett's esophagus and esophageal adenocarcinoma
por: Lv, Jing, et al.
Publicado: (2020)